Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00445887 · ClinicalTrials.gov registry record · Phase 2
Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian Cancer
A Phase 2 study, sponsored by Gynecologic Oncology Group.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
NCT00445887 is a Phase 2 study that has completed, run by Gynecologic Oncology Group. The registered enrollment target is 60 participants.
The verdict
NCT00445887, a Phase 2 study, has completed, sponsored by Gynecologic Oncology Group.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
Study Summary
This randomized phase II trial is studying how well levonorgestrel works in preventing ovarian cancer in patients at high risk for ovarian cancer. Chemoprevention is the use of certain drugs to keep cancer from forming. The use of levonorgestrel may prevent ovarian cancer.
Interventions
- OTHER Placebo
- OTHER Laboratory Biomarker Analysis
- DRUG Levonorgestrel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2008-03-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00445887
The ClinicalTrials.gov registry entry for NCT00445887 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gynecologic Oncology Group, which has 154 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00445887 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00445887 about?
NCT00445887 is a clinical study titled "Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian Cancer". This randomized phase II trial is studying how well levonorgestrel works in preventing ovarian cancer in patients at high risk for ovarian cancer. Chemoprevention is the use of certain drugs to keep cancer from forming. The use of levonorgestrel may prevent ovarian cancer.
What is the current status of trial NCT00445887?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2008-03-10.
What interventions are being tested in trial NCT00445887?
The interventions under investigation include: Placebo (OTHER), Laboratory Biomarker Analysis (OTHER), Levonorgestrel (DRUG).
Who is sponsoring clinical trial NCT00445887?
This trial is sponsored by Gynecologic Oncology Group, which has 154 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.